PEKIN, IL – Reditus Laboratories is excited to announce that it has received accreditation from the College of American Pathologists (CAP). The application for CAP is a lengthy and time-consuming process that
Reditus knew it could achieve under the direction of Dr. Joshua Geltz.
The CAP’s Laboratory Accreditation Program is recognized as the champion of laboratory excellence. The rigorous accreditation process which laboratories undergo to meet these requirements commonly exceed the standards of the Clinical Laboratory Improvement Amendments (CLIA), the U.S. Food and Drug Administration and the Occupational Safety and Health Administration. CAP’s areas of measure include laboratory safety, procedures, training, documentation, and personnel qualifications. The accreditation process also included an on-site visit of an inspection team of practicing lab professionals. Reditus Laboratories was able to meet these requirements with a perfect score in all areas assessed on January 28.
“My goal when opening Reditus Laboratories in April 2018 was to become one of the nation’s top clinical diagnostic laboratories. We have been able to accomplish this even during a pandemic, which speaks volumes to the quality and dedication of our staff, who ensure that the patient always comes first,” said Dr. Aaron Rossi, CEO of Reditus Laboratories.
Reditus Laboratories partners with Peoria-Tazewell Pathology Group for pathology services in order to meet all required regulations. Reditus is honored to accept this prestigious accreditation with a perfect score. Reditus’s dedication to quality, regulatory requirements and patients is proven as Reditus was able to receive this certification in record time for a relatively new laboratory.
“I’m proud of the accomplishments that Reditus has achieved due to the hard work and dedication of our staff,” said Dr. Joshua Geltz, Chief Laboratory Director at Reditus Laboratories. “The company is successful because of the attention to detail and adherence to regulatory requirements which ensure that each sample is held to the same required standards for testing and reporting.”
CAP’s Laboratory Accreditation Program focuses on continuous improvement as accreditation helps labs to exchange ideas and best practices. To maintain accreditation, Reditus will complete a yearly self-assessment and on-site inspections every two years.
“We look forward to the growth of our laboratory post-pandemic and how we can better service our clients,” said Michelle Anderson, manager of the Reditus Clinical Molecular Lab.
By Paul Swiech
Reditus Laboratories is a full-service dermatopathology laboratory company with a heavy focus on molecular diagnostics. Based in Pekin, Illinois, Reditus provides top-tier, accurate anatomical and clinical pathology services, including cytology, histology and molecular testing. Additional information is at www.redituslabs.com, as well as on Facebook at Reditus Laboratories and Twitter @ReditusLabs.